Modulation of the impaired drug metabolism in sarcoma-180-bearing mice by echitamine chloride.

Cancer biochemistry biophysics Pub Date : 1999-07-01
V Saraswathi, V Mathuram, S Subramanian, S Govindasamy
{"title":"Modulation of the impaired drug metabolism in sarcoma-180-bearing mice by echitamine chloride.","authors":"V Saraswathi,&nbsp;V Mathuram,&nbsp;S Subramanian,&nbsp;S Govindasamy","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>Echitamine chloride (EC), an indole alkaloid, extracted from the bark of Alstonia scholaris has got highly promising anticancer effect. The effect of this drug on the microsomal drug detoxifying system was studied in sarcoma-180 induced mice. When given sub-cutaneously at a dosage of 5 mg/kg body weight, it was able to alter the impaired drug detoxifying system which was observed in the Sarcoma-180 bearing mice. The levels of microsomal protein, Cyt-P450, Cyt-b5, NADH-Cyt-C-reductase, NADPH-Cyt-C-reductase, and glu-6 phosphatase were determined. The levels of these drug metabolizing enzymes were decreased in S-180 bearing mice. EC treatment corrected to near normal levels of these enzymes and microsomal hemeproteins. In order to understand the mechanism responsible for the decreased protein level and its normalization after treatment with EC, 3H-Phenylalanine incorporation study was carried out. From the results, it is observed that the synthesis of apoproteins is also altered in tumor-bearing animals. All these changes which were observed in tumor-bearing animals were corrected to near normal levels after treatment with EC.</p>","PeriodicalId":9552,"journal":{"name":"Cancer biochemistry biophysics","volume":"17 1-2","pages":"79-88"},"PeriodicalIF":0.0000,"publicationDate":"1999-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cancer biochemistry biophysics","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Echitamine chloride (EC), an indole alkaloid, extracted from the bark of Alstonia scholaris has got highly promising anticancer effect. The effect of this drug on the microsomal drug detoxifying system was studied in sarcoma-180 induced mice. When given sub-cutaneously at a dosage of 5 mg/kg body weight, it was able to alter the impaired drug detoxifying system which was observed in the Sarcoma-180 bearing mice. The levels of microsomal protein, Cyt-P450, Cyt-b5, NADH-Cyt-C-reductase, NADPH-Cyt-C-reductase, and glu-6 phosphatase were determined. The levels of these drug metabolizing enzymes were decreased in S-180 bearing mice. EC treatment corrected to near normal levels of these enzymes and microsomal hemeproteins. In order to understand the mechanism responsible for the decreased protein level and its normalization after treatment with EC, 3H-Phenylalanine incorporation study was carried out. From the results, it is observed that the synthesis of apoproteins is also altered in tumor-bearing animals. All these changes which were observed in tumor-bearing animals were corrected to near normal levels after treatment with EC.

分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
氯echitamine对180肉瘤小鼠药物代谢受损的调节作用。
氯Echitamine chloride (EC)是从石桐树皮中提取的吲哚类生物碱,具有很好的抗癌作用。研究了该药物对180肉瘤小鼠微粒体药物解毒系统的影响。在携带saroma -180的小鼠中观察到,皮下给药剂量为5mg /kg体重时,能够改变受损的药物解毒系统。测定各组小鼠微粒体蛋白、Cyt-P450、Cyt-b5、nadh - cyt - c -还原酶、nadph - cyt - c -还原酶、葡聚糖-6磷酸酶水平。S-180小鼠体内这些药物代谢酶水平降低。EC治疗使这些酶和微粒体血红蛋白接近正常水平。为了了解EC治疗后蛋白水平下降及其正常化的机制,我们进行了3h -苯丙氨酸掺入研究。结果表明,载脂蛋白的合成在荷瘤动物中也发生了改变。所有这些在荷瘤动物中观察到的变化在用EC治疗后被纠正到接近正常水平。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Lactoferrin expression in human breast cancer. Modulation of the impaired drug metabolism in sarcoma-180-bearing mice by echitamine chloride. Magnetic field induced inhibition of human osteosarcoma cells treated with adriamycin. Modulating effect of new potential antimelanomic agents, spin-labeled triazenes and nitrosoureas on the DOPA-oxidase activity of tyrosinase. Molecular basis of specific inhibition of urokinase plasminogen activator by amiloride.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1